10-QCCCCCIK 0001662579
C4 Therapeutics, Inc.
Quarterly report (10-Q) filed .
Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.
Filing facts
- Accession number
- 0001628280-26-055494
- Filer
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 0001662579
- Form type
- 10-Q
- Form description
- Quarterly report
- Filed at
- August 11, 2026
- Period of report
- 2026-06-30
- Industry
- SIC 2836Biological Products
- Filing size
- 29.6 MB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1662579/000162828026055494/0001628280-26-055494-index.htm ↗Filer's full EDGAR submission history
EDGAR · C4 Therapeutics, Inc. (0001662579) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001628280-26-055494.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.